Brentuximab (Anti-TNFRSF8 / CD30)
Brentuximab (Anti-TNFRSF8 / CD30) (A2322-GRP)
Products
Description
Brentuximab (Anti-TNFRSF8 / CD30) is a chimeric monoclonal antibody targeting anti-CD30 with antineoplastic activity. It has the potential to alter the disease course of non-MF/SS CTCLs. MW : 145.38 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2322 |
| Target | CD markers |